KeyCorp Research Analysts Lower Earnings Estimates for ACHC

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) - Equities research analysts at KeyCorp cut their Q2 2025 EPS estimates for Acadia Healthcare in a note issued to investors on Monday, January 6th. KeyCorp analyst M. Gillmor now anticipates that the company will post earnings per share of $0.85 for the quarter, down from their previous estimate of $1.00. KeyCorp currently has a "Overweight" rating and a $70.00 price target on the stock. The consensus estimate for Acadia Healthcare's current full-year earnings is $3.38 per share. KeyCorp also issued estimates for Acadia Healthcare's Q3 2025 earnings at $0.92 EPS.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. The business had revenue of $815.60 million for the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.91 earnings per share.

Several other brokerages have also weighed in on ACHC. StockNews.com lowered shares of Acadia Healthcare from a "hold" rating to a "sell" rating in a research report on Monday. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a "hold" rating to a "buy" rating and lifted their price objective for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. TD Cowen reduced their price target on Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating for the company in a research report on Tuesday. Cantor Fitzgerald reissued a "neutral" rating and issued a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Finally, Barclays decreased their target price on Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating for the company in a research report on Friday, November 22nd. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $70.22.

Acadia Healthcare Stock Down 0.0 %

Shares of ACHC traded down $0.01 during midday trading on Wednesday, reaching $45.12. 2,543,740 shares of the stock were exchanged, compared to its average volume of 2,378,388. The company has a market cap of $4.19 billion, a price-to-earnings ratio of 14.79, a P/E/G ratio of 1.77 and a beta of 1.29. The firm has a 50 day simple moving average of $40.57 and a 200-day simple moving average of $58.37. Acadia Healthcare has a 12-month low of $36.50 and a 12-month high of $87.77. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Institutional Investors Weigh In On Acadia Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the stock. GAMMA Investing LLC increased its holdings in shares of Acadia Healthcare by 57.1% during the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company's stock worth $42,000 after purchasing an additional 241 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new position in Acadia Healthcare in the 2nd quarter valued at approximately $59,000. Covestor Ltd lifted its position in shares of Acadia Healthcare by 834.4% in the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company's stock worth $72,000 after acquiring an additional 1,018 shares during the period. DekaBank Deutsche Girozentrale acquired a new stake in shares of Acadia Healthcare during the 3rd quarter worth approximately $86,000. Finally, Assetmark Inc. raised its stake in shares of Acadia Healthcare by 66.1% in the third quarter. Assetmark Inc. now owns 1,485 shares of the company's stock valued at $94,000 after purchasing an additional 591 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.